Biospecimens are used across the entire spectrum of research and drug discovery. They are a valuable resource for biomarker discovery, target validation, lead optimization, translational research, and clinical development. Biospecimens (e.g., blood, cerebrospinal fluid, brain tissue) are of irreplaceable importance in stroke research and provide critical support for understanding disease mechanisms and developing new therapies.
Ace Therapeutics is a leading stroke research service provider offering biospecimen collection and analysis services to meet the needs of research institutions and pharmaceutical companies for their stroke research programs. Our team of experienced senior scientists enable to implement rigorous sample quality control measures to provide high-quality biospecimens.
Ace Therapeutics collects, processes, and stores animal biospecimens and cells for stroke drug discovery and diagnostic development. Our samples can be customized to your specifications.
Biofluids (Blood-derived)
Ace Therapeutics offers animal blood-derived biospecimens, available to ship from inventory or through custom collections to meet your specific needs.
Biofluids (Other)
Drive your breakthroughs in stroke diagnosis and therapy forward with a broad range of non-blood biofluids by sourcing and delivering vital data through a global network.
Tissues
Ace Therapeutics' team of on-site pathologists and laboratory specialists provide you with high-quality tissue samples tailored to your stroke research needs. Each biospecimen is properly collected and stored according to your requirements.
Ace Therapeutics provides cell lines derived from human and animal species to support preclinical stroke research. These cells are carefully isolated, cryopreserved, and rigorously tested to ensure cell viability and reliability.
In addition to offering a selection of high-quality characterized biospecimens, Ace Therapeutics provides specialized laboratory services to evaluate animal biospecimens using various technologies, including:
Rigorous Quality Control
Every biospecimen undergoes stringent quality control measures, from collection to analysis. Our protocols ensure sample consistency and reproducibility, meeting the industry standards.
Advanced Technologies
Our advanced technology platforms, including pathology analysis, molecular biology analysis, and genetic analysis, enable our clients to discover key insights into stroke mechanisms and therapeutic targets.
Customized Solutions
Our services are tailored to meet your specific needs, whether you require specialized biospecimen collection, targeted molecular analysis, or end-to-end project support.
Ace Therapeutics provides high-quality biospecimens and specialized services tailored for your stroke research. Through our expertise in managing the intricate processes of biospecimen acquisition, comprehensive testing protocols, and sophisticated data interpretation, we provide strategic guidance throughout every phase of the stroke drug discovery process. If you are interested in our services, please contact us for more information.